|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Valproic acid and all-trans retinoic acid: meta-analysis of a palliative treatment regimen in AML and MDS patients显示文摘 | Bellos F Mahlknecht U | 2008 | Onkologie2008，31，11： | 1 |
| 2 | Aliasing effects mitigation by optimized sampling grids and impact on image acquisition chains 显示文摘 | VITALLI R BELLO U D ARMBRUSTER P | 2002 | IEEE2002，，： | 1 |
| 3 | The major genetic determinants of HIV-1control affect HLA class I peptide presentation显示文摘 | International HIV Controllers Study Pereyra F Jia X McLaren P J Telenti A de Bakker P I Walker B D Ripke S Brumme C J Pulit S L Carrington M Kadie C M Carlson J M Heckerman D Graham R R Plenge R M Deeks S G Gianniny L Crawford G Sullivan J Gonzalez E Davies L Camargo A Moore JM Beattie N Gupta S Crenshaw A Burtt N P Guiducci C Gupta N Gao X Qi Y Yuki Y Piechocka-Trocha A Cutrell E Rosenberg R Moss K L Lemay P O'Leary J Schaefer T Verma P Toth I Block B Baker B Rothchild A Lian J Proudfoot J Alvino D M Vine S Addo M M Allen T M Altfeld M Henn M R Le Gall S Streeck H Haas D W Kuritzkes D R Robbins G K Shafer R W Gulick R M Shikuma C M Haubrich R Riddler S Sax P E Daar E S Ribaudo H J Agan B Agarwal S Ahern R L Allen B L Altidor S Altschuler E L Ambardar S Anastos K Anderson B Anderson V Andrady U Antoniskis D Bangsberg D Barbaro D Barrie W Bartczak J Barton S Basden P Basgoz N Bazner S Bellos N C Benson A M Berger J Bernard N F Bernard A M Birch C Bodner S J Bolan R K Boudreaux E T Bradley M Braun J F Brndjar J E Brown S J Brown K Brown S T Burack J Bush LM Cafaro V Campbell O Campbell J Carlson R H Carmichael J K Casey K K Cavacuiti C Celestin G Chambers S T Chez N Chirch L M Cimoch P J Cohen D Cohn LE Conway B Cooper D A Cornelson B Cox D T Cristofano M V Cuchural G Jr Czartoski J L Dahman J M Daly J S Davis B T Davis K Davod S M DeJesus E Dietz C A Dunham E Dunn M E Ellerin T B Eron J J Fangman J J Farel C E Ferlazzo H Fidler S Fleenor-Ford A Frankel R Freedberg K A French N K Fuchs JD Fuller J D Gaberman J Gallant J E Gandhi R T Garcia E Garmon D Gathe J C Jr Gaultier C R Gebre W Gilman F D Gilson I Goepfert P A Gottlieb M S Goulston C Groger R K Gurley T D Haber S Hardwicke R Hardy W D Harrigan P R Hawkins T N Heath S Hecht F M Henry W K Hladek M Hoffman R P Horton J M Hsu R K Huhn G D Hunt P Hupert M J Illeman M L Jaeger H Jellinger R M John M Johnson J A Johnson K L Johnson H Johnson K Joly J Jordan W C Kauffman C A Khanlou H Killian R K Kim A Y Kim D D Kinder C A Kirchner J T Kogelman L Kojic E M Korthuis P T Kurisu W Kwon D S LaMar M Lampiris H Lanzafame M Lederman M M Lee D M Lee J M Lee M J Lee E T Lemoine J Levy J A Llibre J M Liguori M A Little S J Liu A Y Lopez A J Loutfy M R Loy D Mohammed D Y Man A Mansour M K Marconi V C Markowitz M Marques R Martin J N Martin H L Jr Mayer K H McElrath M J McGhee T A McGovern B H McGowan K McIntyre D Mcleod GX Menezes P Mesa G Metroka CE Meyer-Olson D Miller A O Montgomery K Mounzer K C Nagami E H Nagin I Nahass R G Nelson M O Nielsen C Norene D L O'Connor D H Ojikutu B O Okulicz J Oladehin O O Oldfield E C Olender S A Ostrowski M Owen WF Jr Pae E Parsonnet J Pavlatos A M Perlmutter A M Pierce M N Pincus J M Pisani L Price L J Proia L Prokesch R C Pujet H C Ramgopal M Rathod A Rausch M Ravishankar J Rhame F S Richards C S Richman D D Rodes B Rodriguez M Rose R C 3rd Rosenberg E S Rosenthal D Ross P E Rubin D S Rumbaugh E Saenz L Salvaggio M R Sanchez WC Sanjana V M Santiago S Schmidt W Schuitemaker H Sestak P M Shalit P Shay W Shirvani V N Silebi V I Sizemore J M Jr Skolnik P R Sokol-Anderson M Sosman J M Stabile P Stapleton J T Starrett S Stein F Stellbrink H J Sterman FL Stone V E Stone D R Tambussi G Taplitz R A Tedaldi E M Telenti A Theisen W Torres R Tosiello L Tremblay C Tribble M A Trinh P D Tsao A Ueda P Vaccaro A Valadas E Vanig T J Vecino I Vega V M Veikley W Wade B H Walworth C Wanidworanun C Ward D J Warner D A Weber R D Webster D Weis S Wheeler D A White D J Wilkins E Winston A Wlodaver C G van't Wout A Wright D P Yang O O Yurdin D L Zabukovic B W Zachary K C Zeeman B Zhao M | 2010 | Science2010，330，6010： | 1 |
| 4 | Valproic acid and all-trans retinoic acid:meta-analysis of palliative treatment regimen in AML and MDS patients显示文摘 | Bellos F Mahlknecht U | 2008 | Onkologie2008，31，： | 1 |
| 5 | Valproic acid and all-trans retinoic acid:meta-analysis of a palliative treatment regimen in AML and MDS patients显示文摘 | Bellos F Mahlknecht U | 2008 | Onkologie2008，31，11： | 1 |
| 6 | Valproic acid and all-trans retinoic acid: meta-analysis of a palliative treatment regimen in AML and MDS patients显示文摘 | Bellos F Mahlknecht U | 2008 | Onkologie2008，31，11： | 1 |
| 7 | The outcome of patients with diffuse large B-Cell lymphoma (DLBCL) treated with Ritux-imab-CHOP (R-CHOP) is not predicted by 18-FDG-Positron Emission Tomography/Computerized Tomography (PET) performed at intermediate in-course evaluation,but only by PET a显示文摘 | Vitolo U Chiappella A Bello M | | 0，，： | 1 |
| 8 | Valproic acid and all-trans refincic acid: meta-analysis of a palliative treatment regimen in AML and MDS patients 显示文摘 | BELLOS F MAHLKNECHT U | 2008 | Onkologie2008，31，11： | 1 |
| 9 | Bovine Herpesvirus-las a Livevirus Vector for Expression of Foreign Genes显示文摘 | LEONARD J BELLO U CHARLES W | 1992 | Virology1992，190，： | 1 |
| 10 | Real-world cure rates for hepatitis C virus treatments that include simeprevir and/or sofosbuvir are comparable to clinical trial results显示文摘AIM To assess the real-world effectiveness and cost of simeprevir(SMV), and/or sofosbuvir(SOF)-based therapy for chronic hepatitis C virus(HCV) infection.METHODS The real-world performance of patients treated with SMV/SOF ± ribavirin(RBV), SOF/RBV, and SOF/RBV with pegylated-interferon(PEG) were analyzed in a consecutive series of 508 patients with chronic HCV infection treated at a single academic medical center. Patients with genotypes 1 through 4 were included. Rates of sustained virological response-the absence of a detectable serum HCV RNA 12 wk after the end of treatment [sustained virological response(SVR) 12]-were calculated on an intention-to-treat basis. Costs were calculated from the payer's perspective using Medicare/Medicaid fees and Redbook Wholesale Acquisition Costs. Patient-related factors associated with SVR12 were identified using multivariable logistic regression.RESULTS SVR 12 rates were as follows: 86%(95%CI: 80%-91%)among 178 patients on SMV/SOF ± RBV; 62%(95%CI: 55%-68%) among 234 patients on SOF/RBV; and 78%(95%CI: 68%-86%) among 96 patients on SOF/PEG/RBV. Mean costs-per-SVR 12 were $174442(standard deviation: ± $18588) for SMV/SOF ± RBV; $223003(± $77946) for SOF/RBV; and $126496(± $31052) for SOF/PEG/RBV. Among patients on SMV/SOF ± RBV, SVR12 was less likely in patients previously treated with a protease inhibitor [odds ratio(OR): 0.20, 95%CI: 0.06-0.56]. Higher bilirubin(OR: 0.47, 95%CI: 0.30-0.69) reduced the likelihood of SVR12 among patients on SOF/RBV, while FIB-4 score ≥ 3.25 reduced the likelihood of SVR 12(OR: 0.18, 95%CI: 0.05-0.59) among those on SOF/PEG/RBV. CONCLUSION SVR 12 rates for SMV and/or SOF-based regimens in a diverse real-world population are comparable to those in clinical trials. Treatment failure accounts for 27% of costs. | Kian Bichoupan Neeta Tandon James F Crismale Joshua Hartman David Del Bello Neal Patel Sweta Chekuri Alyson Harty Michel Ng Keith M Sigel Meena B Bansal Priya Grewal Charissa Y Chang Jennifer Leong Gene Y Im Lawrence U Liu Joseph A Odin Nancy Bach Scott L Friedman Thomas D Schiano Ponni V Perumalswami Douglas T Dieterich Andrea D Branch | 2017 | World Journal of Virology2017，6，4： | 1 |
| 11 | Bovine herpesvirus-las a live virus vector for expression of foreign genes 显示文摘 | Leonard J Bello U Charles W | 1992 | Virology1992，190，： | 1 |
| 12 | The effects on steroidogenesis and histopathology of adult male Japanese quails(Coturnix coturnix japonica)testis following pre-pubertal exposure to di(n-butyl)phthalate(DBP)显示文摘 | Bello U M Madekurozwa M C Groenewald H B | 2014 | Comparative Biochemistry And Physiology2014，166，： | 1 |
| 13 | Bovine herpesvirus-1 as a live virus vector for expression of foreign genes显示文摘 | Leonard J Bello U Charles W | 1992 | Virology1992，190，： | 1 |
| 14 | Bovine herpesvirus-1 as a live virus vector for expression of foreign genes 显示文摘 | Leonard J Bello U Charles W | 1992 | Virology1992，190，： | 1 |
| 15 | Valpmic acid and all-trans retinoic acid: meta-analysis of a palliative treatment regimen in AML and MDS patients 显示文摘 | Bellos F Mahlknecht U | 2008 | Oncology2008，31，11： | 1 |
| 16 | Ponseti method treatment of neglected idiopathic clubfoot:Preliminary results of a multi-center study in Nigeria显示文摘AIM To evaluate the effectiveness of the Ponseti method for initial correction of neglected clubfoot cases in multiple centers throughout Nigeria.METHODS Patient charts were reviewed through the International Clubfoot Registry for 12 different Ponseti clubfoot treatment centers and 328 clubfeet(225 patients) met inclusion criteria. All patients were treated by the method described by Ponseti including manipulation and casting with percutaneous Achilles tenotomy as needed.RESULTS A painless plantigrade foot was obtained in 255 feet(78%) without the need for extensive soft tissue release and/or bony procedures.CONCLUSION We conclude that the Ponseti method is a safe, effective and low-cost treatment for initial correction of neglected idiopathic clubfoot presenting after walking age. Longterm follow-up will be required to assess outcomes. | Olayinka O Adegbehingbe Adeoye J Adetiloye Ladipo Adewole Dennis U Ajodo Nosirudeen Bello Oluwadare Esan Alex C Hoover James Ior Omolade Lasebikan Owolabi Ojo Anthony Olasinde David Songden Jose A Morcuende | 2017 | World Journal of Orthopedics2017，8，8： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员